STOCK PLUMMETS AFTER NOVO NORDISK DEAL FAILURE

Shares of HIMS experienced a dramatic decline today following the unexpected withdrawal of its deal with pharmaceutical giant Novo Nordisk. Investors interpreted negatively to the news, sending HIMS's stock price plummeting by over 20%. The reason for the breakdown of the partnership remains unclear, but industry analysts speculate that it could be